ResMed | RMD - Debt


ResMed reported $843.17M in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Ansell USD 805.6M 51.6M Jun/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 71.78M 1.6M Mar/2026
Baxter International USD 9.69B 93M Mar/2026
Cochlear AUD 235.7M 10.9M Jun/2025
Cooper Companies USD 2.5B 5.6M Dec/2025
CSL USD 11.96B 219M Dec/2024
Dexcom USD 1.24B 900K Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Globus Medical USD 115.22M 3.43M Mar/2026
Haemonetics USD 1.22B 153K Mar/2026
Idexx Laboratories USD 1.1B 9.37M Jun/2026
Inogen USD 0 0 Jun/2022
Insulet USD 948.4M 300K Jun/2026
Integra LifeSciences USD 2.04B 6.27M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
Medtronic USD 27.96B 110M Mar/2026
Philips EUR 7.47B 632M Jun/2026
Ramsay Health Care AUD 12.12B 864.4M Jun/2025
ResMed USD 843.17M 4.55M Mar/2026
Sigma Healthcare AUD 137.64M 1.01M Jul/2024
Sonic Healthcare AUD 4.8B 282.9M Dec/2024
Steris USD 2.09B 33.5M Mar/2026
Teleflex USD 2.69B 39.95M Mar/2026
Thermo Fisher Scientific USD 43.16B 3.78B Mar/2026